促销活动

【惊喜八月】菲恩生物夏季活动进行中…

NO.1夏/季/蛋/白/活/动

6折促销

炎炎夏日

菲恩生物清凉送“第一炮”

库存 3000 

重组蛋白产品

6折促销中...

● 库存蛋白详情请点击 →库存3000种蛋白

● 活动最终解释权归菲恩生物所有。

NO.2夏/季/抗/体/活/动

买三送一

● 菲恩生物清凉送“第二炮”

● 买任意三支一抗就送“内参抗体”哦!

内/参/抗/体/列/表

【FNab00278】anti- Albumin antibody

【FNab00333】anti- alpha Tubulin antibody

【FNab00691】anti- ATP1A1 antibody

【FNab00869】anti- beta actin antibody

【FNab03342】anti- GAPDH antibody

【FNab04681】anti- Lamin A/C antibody

【FNab04682】anti- Lamin B1 antibody

【FNab06215】anti- PCNA antibody

【FNab06217】anti- PCNA antibody

【FNab08929】anti- Transferrin antibody

【FNab09799】anti- Vinculin antibody

【FNab09826】anti- VDAC1/Porin antibody

【FNab09872】anti- Beta Tubulin antibody

【FNab10027】anti- YY1 antibody

【FNab10263】anti- TBP antibody

活动日期:2022.08.1~2022.08.30

参 考 文 献:

  1. 《Biological Research》miR-185-5p response to usnic acid suppresses proliferation and regulating apoptosis in breast cancer cell by targeting Bcl2(IF=2.482)
  2. 《Scientific Reports》Short-term exposure to air pollution (PM2.5) induces hypothalamic inflammation, and long-term leads to leptin resistance and obesity via Tlr4/Ikbke in mice(IF=4.847)
  3. 《Molecules》Harringtonine Inhibits Zika Virus Infection through Multiple Mechanisms(IF=3.267)
  4. 《Frontiers in Bioscience-Landmark》Pteropine Orthoreovirus, PRV7S (Sikamat Virus) Demonstrates Oncolysis in Nasopharyngeal Carcinoma Cell Lines(IF=4.009)
  5. 《OncoTargets and Therapy》lncRNA NEAT1 Facilitates Cell Proliferation, Invasion and Migration by Regulating CBX7 and RTCB in Breast Cancer(IF=3.046)
  6. 《Experimental and Therapeutic Medicine》Expression levels of CXCR4 and CXCL12 in patients with rheumatoid arthritis and its correlation with disease activity(IF=1.785)
  7. 《American Journal of Translational Research》The effects of radiotherapy after thoracic and laparoscopic surgery on patients with esophageal cancer and on their prognoses(IF=4.06)
  8. 《Oxidative Medicine and Cellular Longevity》MKRN1 Ubiquitylates p21 to Protect against Intermittent Hypoxia-Induced Myocardial Apoptosis(IF=6.543)